Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naohiko Fujii

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Nihon Jinzo Gakkai Shi|January 29, 2016
[Community-based CKD study in Japan]Naohiko Fujii
Clinical Calcium|November 27, 2014
[New Developments in CKD-MBD. The management of posttransplant CKD-MBD : When, Who, and How?]Naohiko Fujii
Clinical Calcium|June 30, 2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). CKD-MBD in CKD patients not yet on dialysis; Status Quo]Naohiko Fujii
Clinical Calcium|July 28, 2018
[Bone and Mineral Metabolism in Hemodialysis Patients. Fragility Fractures in Hemodialysis Patients.]Naohiko Fujii
Organic & Biomolecular Chemistry|August 31, 2007
A novel proton-selective sensor based on a sugar with hinge flexibilityHideya Yuasa, Naohiko Fujii, Shun Yamazaki
Nihon Jinzo Gakkai Shi|May 2, 2013
[Management of CKD-MBD in kidney transplant patients]Yoshitaka Isaka, Naohiko Fujii, Hiromi Rakugi
Clinical and Experimental Nephrology|December 13, 2016
Clinical features of CKD-MBD in Japan: cohort studies and registryTakayuki Hamano, Yusuke Sakaguchi, Naohiko Fujii, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 15, 2005
Different routes bridging calcium in Japanese hemodialysis patientsTakayuki Hamano, Naohiko Fujii, Takahito Ito, et al.
NDT Plus|June 29, 2017
Successful treatment for thrombotic thrombocytopenic purpura complicated with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitisYoko Yamauchi, Katsuyuki Nagatoya, Ayako Okuno, et al.
Journal of Nephrology|January 5, 2024
Low-dosage active vitamin D modifies the relationship between hypocalcemia and overhydration in patients with advanced chronic kidney diseaseSatoshi Yamaguchi, Takayuki Hamano, Sayoko Yonemoto, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Nihon Jinzo Gakkai Shi|January 29, 2016
[Community-based CKD study in Japan]Naohiko Fujii
Clinical Calcium|November 27, 2014
[New Developments in CKD-MBD. The management of posttransplant CKD-MBD : When, Who, and How?]Naohiko Fujii
Clinical Calcium|June 30, 2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). CKD-MBD in CKD patients not yet on dialysis; Status Quo]Naohiko Fujii
Clinical Calcium|July 28, 2018
[Bone and Mineral Metabolism in Hemodialysis Patients. Fragility Fractures in Hemodialysis Patients.]Naohiko Fujii
Organic & Biomolecular Chemistry|August 31, 2007
A novel proton-selective sensor based on a sugar with hinge flexibilityHideya Yuasa, Naohiko Fujii, Shun Yamazaki
Nihon Jinzo Gakkai Shi|May 2, 2013
[Management of CKD-MBD in kidney transplant patients]Yoshitaka Isaka, Naohiko Fujii, Hiromi Rakugi
Clinical and Experimental Nephrology|December 13, 2016
Clinical features of CKD-MBD in Japan: cohort studies and registryTakayuki Hamano, Yusuke Sakaguchi, Naohiko Fujii, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 15, 2005
Different routes bridging calcium in Japanese hemodialysis patientsTakayuki Hamano, Naohiko Fujii, Takahito Ito, et al.
NDT Plus|June 29, 2017
Successful treatment for thrombotic thrombocytopenic purpura complicated with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitisYoko Yamauchi, Katsuyuki Nagatoya, Ayako Okuno, et al.
Journal of Nephrology|January 5, 2024
Low-dosage active vitamin D modifies the relationship between hypocalcemia and overhydration in patients with advanced chronic kidney diseaseSatoshi Yamaguchi, Takayuki Hamano, Sayoko Yonemoto, et al.
Pageof 9